These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34493179)

  • 1. SARS-CoV-2 public health investigation in an aged care facility and challenges with serological screening in low pre-test probability settings.
    Smoll NR; Taylor C; Martin R; Wheatley S; Moore P; Finger M; Moore F; Schlebusch S; Khandaker G
    Commun Dis Intell (2018); 2021 Aug; 45():. PubMed ID: 34493179
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of selected SARS-CoV-2 antibodies immunoassays.
    Mohd Zain R; Shaiful Bahrin NI; Ellan K; Thayan R
    Malays J Pathol; 2021 Dec; 43(3):463-464. PubMed ID: 34958069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
    Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
    J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak.
    Carta M; Bragagnolo L; Tramarin A; Cappelletti A; Barzon E; Forner L; Meneghini MG; Tripodi C; Gottardo M; Dal Lago F; Marinello S; Dal Grande G; Pascarella M; Rassu M; Giavarina D
    Clin Chem Lab Med; 2021 Jul; 59(8):e322-e325. PubMed ID: 33641271
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
    Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
    Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China.
    Liao M; Yan J; Wang X; Qian H; Wang C; Xu D; Wang B; Yang B; Liu S; Zhou M; Gao Q; Zhou Q; Luo J; Li Z; Liu W
    J Clin Lab Anal; 2021 Jan; 35(1):e23619. PubMed ID: 33067888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department.
    Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Quarto M; Procacci V; Chironna M
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32906596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.